← Leaderboards
Eric C Strain
Johns Hopkins University
$21,082,541
Attributed
$23,875,286
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,875,286 · 10
FDA$1,000,000 · 1
By mechanism
R01$16,572,082 · 5
T32$2,760,787 · 1
K24$1,848,126 · 1
U01$1,000,000 · 1
K02$884,291 · 1
K12$810,000 · 1
Top collaborators
- Elise M Weerts5 shared
- Robert H Dworkin2 shared
- James C Eisenach2 shared
- Justin Charles Strickland2 shared
- Lena S Sun2 shared
- Dennis C. Turk2 shared
- George Bigelow1 shared
- Carlos Austin Zamarripa1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Kelly E Dunn$16,976,262
- Claudia Michelle Campbell$14,946,130
- Renan C Castillo$6,430,047
- Steven P Cohen$4,899,825
- Robert A Anders$7,477,042
Others in their field
Top investigators on “Buprenorphine”
- Sharon L. Walsh · University Of Kentucky$87,310,858
- Edward V Nunes · Columbia University Health Sciences$83,345,625
- T John Winhusen · University Of Cincinnati$34,249,969
- Walter Nmn Ling · University Of California Los Angeles$33,859,118
- Marco Pravetoni · Hennepin Healthcare Research Institute$33,709,846
- George E Woody · University Of Pennsylvania$33,075,022
Research focus
BuprenorphinePharmaceutical PreparationsOpioidDoseClinical ResearchClinical TrialsDrug AbuseWithdrawalUnited StatesSafetyPersonsAgonistFundingReportingNaloxoneOralAnalgesicsInnovationOpiate AddictionDrug Abuse ChemotherapyHuman SubjectHuman Therapy EvaluationOpioid WithdrawalGrant
Grant awards (56)
Johns Hopkins K12 Research in Addictions Scholars Program (KRASP)$810,000
K12 · FY2025 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$670,632
T32 · FY2025 · DA · contact PI
Evaluating kratom using a human drug development methodology$597,896
R01 · FY2025 · DA
Human Behavioral Pharmacology of Substance Abuse$626,100
T32 · FY2024 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$255,079
T32 · FY2023 · DA · contact PI
Analgesic, Anesthetic and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks and Pediatric Anesthesia Safety Initiative (ACTTION/PASI) (U01)$200,000
U01 · FY2023 · FD
Analgesic, Anesthetic and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks and Pediatric Anesthesia Safety Initiative (ACTTION/PASI) (U01)$800,000
U01 · FY2022 · FD
An Innovative Intervention for OUD Treatment$768,145
R01 · FY2022 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$625,288
T32 · FY2022 · DA · contact PI
An Innovative Intervention for OUD Treatment$768,145
R01 · FY2021 · DA · contact PI
Human Behavioral Pharmacology of Substance Abuse$583,688
T32 · FY2021 · DA · contact PI
An Innovative Intervention for OUD Treatment$774,845
R01 · FY2020 · DA · contact PI
Mentoring of Clinical Investigators in Patient Oriented Research$185,680
K24 · FY2016 · DA · contact PI
Mentoring of Clinical Investigators in Patient Oriented Research$185,680
K24 · FY2015 · DA · contact PI
Medications Development for Drug Abuse Disorders$566,561
R01 · FY2014 · DA · contact PI
Mentoring of Clinical Investigators in Patient Oriented Research$185,680
K24 · FY2014 · DA · contact PI
Medications Development for Drug Abuse Disorders$627,473
R01 · FY2013 · DA · contact PI
Mentoring of Clinical Investigators in Patient Oriented Research$185,680
K24 · FY2013 · DA · contact PI
Medications Development for Drug Abuse Disorders$659,857
R01 · FY2012 · DA · contact PI
Mentoring of Clinical Investigators in Patient Oriented Research$185,680
K24 · FY2012 · DA · contact PI
Medications Development for Drug Abuse Disorders$599,413
R01 · FY2011 · DA · contact PI
Mentoring of Clinical Investigators in Patient Oriented Research$184,113
K24 · FY2011 · DA · contact PI
Evaluation of Opioid Antagonist Activity in Humans$714,902
R01 · FY2010 · DA · contact PI
Medications Development for Drug Abuse Disorders$433,294
R01 · FY2010 · DA · contact PI
Mentoring of Clinical Investigators in Patient Oriented Research$184,117
K24 · FY2010 · DA · contact PI
Evaluation of Opioid Antagonist Activity in Humans$705,070
R01 · FY2009 · DA · contact PI
Mentoring of Clinical Investigators in Patient Oriented Research$184,121
K24 · FY2009 · DA · contact PI
Evaluation of Opioid Antagonist Activity in Humans$685,517
R01 · FY2008 · DA · contact PI
Medications Development for Drug Abuse Disorders$472,726
R01 · FY2008 · DA · contact PI
Mentoring of Clinical Investigators in Patient Oriented Research$184,124
K24 · FY2008 · DA · contact PI
Evaluation of Opioid Antagonist Activity in Humans$679,189
R01 · FY2007 · DA · contact PI
Medications Development for Drug Abuse Disorders$468,361
R01 · FY2007 · DA · contact PI
Mentoring of Clinical Investigators in Patient Oriented Research$183,251
K24 · FY2007 · DA · contact PI
Evaluation of Opioid Antagonist Activity in Humans$648,788
R01 · FY2006 · DA · contact PI
Medications Development for Drug Abuse Disorders$468,330
R01 · FY2006 · DA · contact PI
Clinical Research on Drug Abuse$125,388
K02 · FY2006 · DA · contact PI
Medications Development for Drug Abuse Disorders$465,669
R01 · FY2005 · DA
SEROTONIN Treatment of Cocaine Dependence$435,024
R01 · FY2005 · DA
EVALUATION OF OPIOID ANTAGONIST ACTIVITY IN HUMANS$402,190
R01 · FY2005 · DA
Clinical Research on Drug Abuse$125,388
K02 · FY2005 · DA
SEROTONIN Treatment of Cocaine Dependence$695,509
R01 · FY2004 · DA
Medications Development for Drug Abuse Disorders$463,830
R01 · FY2004 · DA
EVALUATION OF OPIOID ANTAGONIST ACTIVITY IN HUMANS$381,275
R01 · FY2004 · DA
Clinical Research on Drug Abuse$125,388
K02 · FY2004 · DA
EVALUATION OF OPIOID ANTAGONIST ACTIVITY IN HUMANS$10,140
R01 · FY2004 · DA
SEROTONIN Treatment of Cocaine Dependence$675,286
R01 · FY2003 · DA
EVALUATION OF OPIOID ANTAGONIST ACTIVITY IN HUMANS$370,166
R01 · FY2003 · DA
Clinical Research on Drug Abuse$125,388
K02 · FY2003 · DA
SEROTONIN Treatment of Cocaine Dependence$655,658
R01 · FY2002 · DA
EVALUATION OF OPIOID ANTAGONIST ACTIVITY IN HUMANS$359,385
R01 · FY2002 · DA
Clinical Research on Drug Abuse$125,388
K02 · FY2002 · DA
SEROTONIN Treatment of Cocaine Dependence$655,760
R01 · FY2001 · DA
EVALUATION OF OPIOID ANTAGONIST ACTIVITY IN HUMANS$363,678
R01 · FY2001 · DA
CLINICAL RESEARCH ON DRUG ABUSE$129,465
K02 · FY2001 · DA
CLINICAL RESEARCH ON DRUG ABUSE$127,886
K02 · FY2000 · DA
TRYPTOPHAN AND BEHAVIOR THERAPY FOR COCAINE ABUSE$0
M01 · FY2000 · RR